About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
325 genotypes with 402 annotations displayed of selected term and subterms
Searched Term: increased nervous system tumor incidence
Allelic Composition
(Genetic Background)		 Annotated Term Reference
\Actn4tm1a(EUCOMM)Wtsi/\Actn4tm1a(EUCOMM)Wtsi
(C57BL/6N-Actn4tm1a(EUCOMM)Wtsi/Wtsi) 		increased trigeminal neuroma incidence J:239583
\Acvr1tm1Mak/\Acvr1+
\Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/\Gt(ROSA)26Sor+
\H3c2tm1Mak/\H3c2+
\Olig2tm1.1(cre)Wdr/\Olig2+
(involves: 129 * C57BL/6 * FVB/N) 		increased brain tumor incidence J:285841
increased glioma incidence J:285841
\Acvr1tm1Mak/\Acvr1+
\Gt(ROSA)26Sortm1(Pik3ca*H1047R)Egan/\Gt(ROSA)26Sor+
\Olig2tm1.1(cre)Wdr/\Olig2+
(involves: 129 * C57BL/6 * FVB/N) 		increased brain tumor incidence J:285841
increased glioma incidence J:285841
\Adamts3tm1b(KOMP)Wtsi/\Adamts3tm1b(KOMP)Wtsi
(C57BL/6N-Adamts3tm1b(KOMP)Wtsi/Wtsi) 		increased trigeminal neuroma incidence J:239583
\Aicdatm1(cre)Mnz/\Aicda+
\Gt(ROSA)26Sortm2(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6070Njen/0
(involves: 129 * 129P2/OlaHsd * C57BL/6 * C57BL/6J) 		increased medulloblastoma incidence J:153656
\AipGt(RRI002)Byg/\Aip+
(involves: 129P2/OlaHsd * C57BL/6) 		increased pituitary adenoma incidence J:165349
increased prolactinoma incidence J:165349
\Alktm1.1(ALK*F1174L)Heno/\Alk+
\Tg(Mpz-cre)94Imeg/0
\Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6 * SJL) 		increased neuroblastoma incidence J:294092
\Alktm1.1(ALK*F1174L)Heno/\Alktm1.1(ALK*F1174L)Heno
\Tg(Mpz-cre)94Imeg/0
\Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6 * SJL) 		increased neuroblastoma incidence J:294092
\Alktm1.1Ics/?
\Tg(Th-MYCN)41Waw/0
(involves: 129S2/SvPas * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6J) 		increased neuroblastoma incidence J:261033, J:228124
\Alktm2.1Ics/?
\Tg(Th-MYCN)41Waw/0
(involves: 129S2/SvPas * 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6J) 		increased neuroblastoma incidence J:261033, J:228124
\Atp11atm1a(KOMP)Wtsi/\Atp11atm1a(KOMP)Wtsi
(C57BL/6N-Atp11atm1a(KOMP)Wtsi/Wtsi) 		increased trigeminal neuroma incidence J:239583
\Brca2tm1Brn/\Brca2tm1Brn
\Ptch1tm1Mps/\Ptch1+
\Trp53tm1Tyj/\Trp53+
\Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
\Brca2tm1Brn/\Brca2tm1Brn
\Ptch1tm1Mps/\Ptch1+
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(Nes-cre)1Kln/0
(involves: 129 * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
\Brca2tm1Brn/\Brca2tm1Brn
\Trp53tm1Tyj/\Trp53+
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
\Brca2tm1Brn/\Brca2tm1Brn
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
\Brip1Gt(RRI409)Byg/\Brip1Gt(RRI409)Byg
(involves: 129P2/OlaHsd) 		increased pituitary adenoma incidence J:227115
\Bub1tm1.1Tvd/\Bub1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased brain tumor incidence J:143035
\Capza2tm1b(KOMP)Wtsi/\Capza2tm1b(KOMP)Wtsi
(C57BL/6N-Capza2tm1b(KOMP)Wtsi/Wtsi) 		increased trigeminal neuroma incidence J:239583
\Ccnd1tm1Dsn/\Ccnd1tm1Dsn
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129 * C57BL/6) 		increased pituitary adenoma incidence J:66707
\Cdk4tm1.1Bbd/\Cdk4+
\Krastm1Bbd/\Kras+
\Tg(CMV-cre)1Cgn/?
(involves: 129S1/Sv * 129X1/SvJ * BALB/cJ * C57BL/6) 		increased pituitary adenoma incidence J:86101
\Cdkn1btm1Ako/\Cdkn1btm1Ako
(involves: 129S1/Sv * C57BL/6) 		increased pituitary gland tumor incidence J:50053
\Cdkn1btm1Ako/\Cdkn1btm1Ako
\Cdkn2ctm1Yxi/\Cdkn2ctm1Yxi
(involves: 129/Sv * 129S1/Sv * C57BL/6 * DBA/2) 		increased pituitary adenoma incidence J:50053
\Cdkn1btm1Ako/\Cdkn1btm1Ako
\Men1tm1.1Ctre/\Men1+
(involves: 129S1/Sv * 129S6/SvEvTac * C57BL/6) 		increased pituitary gland tumor incidence J:120835
\Cdkn1btm1Kin/\Cdkn1btm1Kin
(involves: 129P2/OlaHsd * C57BL/6) 		increased pituitary adenoma incidence J:33402
\Cdkn1btm1Mlf/\Cdkn1b+
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		increased medulloblastoma incidence J:205254
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
(involves: 129S4/SvJaeSor * C57BL/6J) 		increased pituitary adenoma incidence J:33400
\Cdkn1btm1Mlf/\Cdkn1btm1Mlf
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129S4/SvJaeSor * 129X1/SvJ * C57BL/6) 		increased medulloblastoma incidence J:205254
\Cdkn1btm2Mlf/\Cdkn1btm2Mlf
\Tg(Pomc1-cre)1Mlf/0
(involves: 129S4/SvJaeSor) 		increased pituitary gland tumor incidence J:107588
\Cdkn1btm3Mlf/\Cdkn1btm3Mlf
(involves: 129S4/SvJaeSor) 		increased pituitary gland tumor incidence J:107588
\Cdkn2atm1.1Brn/\Cdkn2atm1.1Brn
\Nf2tm2Gth/\Nf2tm2Gth
(involves: 129P2/OlaHsd * FVB/N) 		increased meningioma incidence J:131179
\Cdkn2atm1.1Brn/\Cdkn2atm1.1Brn
\Nf2tm2Gth/\Nf2tm2Gth
\Ptgdstm1.1(cre)Gvn/\Ptgds+
(involves: 129P2/OlaHsd * FVB/N) 		increased meningioma incidence J:173718
\Cdkn2atm1.1Brn/\Cdkn2atm1.1Brn
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased Schwannoma incidence J:132943
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
\Tg(GFAP-TVA)5Hev/0
(involves: 129X1/SvJ * BALB/c * C57BL/6 * FVB/N) 		increased glioma incidence J:125535
increased oligodendroglioma incidence J:125535
\Cdkn2atm1Cjs/\Cdkn2atm1Cjs
\Tg(NES-TVA)J12Ech/0
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased glioma incidence J:125535
increased oligodendroglioma incidence J:125535
\Cdkn2atm1Rdp/\Cdkn2a+
\Nf1tm1Tyj/\Nf1+
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased neurofibrosarcoma incidence J:131914
\Cdkn2atm1Rdp/\Cdkn2a+
\Tg(NES-TVA)J12Ech/0
(involves: 129 * C57BL/6 * FVB/N * SJL) 		increased glioma incidence J:52161
\Cdkn2atm1Rdp/\Cdkn2a+
\Tg(S100b-v-erbB)4496Waw/0
(involves: 129/Sv * C57BL/6J * DBA/2J * FVB/N * SJL) 		increased glioma incidence J:82649
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
(involves: 129/Sv * C57BL/6J * SJL) 		increased brain tumor incidence J:163931
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Col1a1tm1(CAG-EGFR)Char/\Col1a1tm1(CAG-EGFR)Char
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * SJL) 		increased glioblastoma incidence J:146494
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Col1a1tm1(CAG-EGFR)Char/\Col1a1tm2(CAG-EGFR*)Char
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * SJL) 		increased glioblastoma incidence J:146494
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Col1a1tm2(CAG-EGFR*)Char/\Col1a1tm2(CAG-EGFR*)Char
\Ptentm1Hwu/\Ptentm1Hwu
(involves: 129/Sv * 129S4/SvJae * C57BL/6 * SJL) 		increased glioblastoma incidence J:146494
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Nf1tm1Tyj/\Nf1+
(involves: 129S2/SvPas * 129S6/SvEvTac) 		increased neurofibrosarcoma incidence J:131914
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Tg(GFAP-TVA)5Hev/0
(involves: 129/Sv * BALB/c * C57BL/6 * FVB/N * SJL) 		increased glioma incidence J:125535
increased oligodendroglioma incidence J:125535
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Tg(GFAP-TVA)10Ech/0
(involves: 129 * BALB/c * C57BL/6 * FVB/N * SJL) 		increased glioma incidence J:52161
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Tg(NES-TVA)J12Ech/0
(involves: 129 * C57BL/6 * FVB/N * SJL) 		increased glioma incidence J:52161
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Tg(NES-TVA)J12Ech/0
(involves: 129/Sv * C57BL/6 * FVB/N * SJL) 		increased glioma incidence J:125535
increased oligodendroglioma incidence J:153220
\Cdkn2atm1Rdp/\Cdkn2atm1Rdp
\Tg(S100b-v-erbB)4496Waw/0
(involves: 129/Sv * C57BL/6J * DBA/2J * FVB/N * SJL) 		increased glioma incidence J:82649
increased oligodendroglioma incidence J:82649
\Cdkn2atm2.1Rdp/\Cdkn2atm2.1Rdp
\Tg(GFAP-TVA)5Hev/0
(involves: 129S6/SvEvTac * BALB/c * C57BL/6 * FVB/N) 		increased glioma incidence J:125535
increased oligodendroglioma incidence J:125535
\Cdkn2atm2.1Rdp/\Cdkn2atm2.1Rdp
\Tg(NES-TVA)J12Ech/0
(involves: 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased glioma incidence J:125535
increased oligodendroglioma incidence J:125535
\Cdkn2atm2Brn/\Cdkn2atm2Brn
\Tg(Tyr-cre/ERT,-Hras1*,-Trap1a)10BJvde/0
(involves: C57BL/6 * FVB/N) 		increased neurofibrosarcoma incidence J:107175
\Cdkn2atm4Rdp/\Cdkn2atm4Rdp
\Nf1tm1Par/\Nf1tm1Par
(involves: 129S1/Sv * 129X1/SvJ) 		increased neurofibrosarcoma incidence J:234760
\Cdkn2btm1Bbd/\Cdkn2btm1Bbd
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased pituitary adenoma incidence J:63299
\Cdkn2ctm1Bbd/\Cdkn2c+
\Trp53tm1Tyj/\Trp53+
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased medulloblastoma incidence J:102702
\Cdkn2ctm1Bbd/\Cdkn2c+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased medulloblastoma incidence J:102702
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
(involves: 129S1/Sv * C57BL/6) 		increased pituitary adenoma incidence J:63299
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
\Cdkn2dtm1Maro/\Cdkn2dtm1Maro
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6) 		increased pituitary adenoma incidence J:68829
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ) 		increased medulloblastoma incidence J:102702
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased medulloblastoma incidence J:205254
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
\Trp53tm1Brn/\Trp53tm1Tyj
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:102702
\Cdkn2ctm1Bbd/\Cdkn2ctm1Bbd
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased medulloblastoma incidence J:102702
\Cdkn2ctm1Yxi/\Cdkn2ctm1Yxi
(involves: 129/Sv * C57BL/6 * DBA/2) 		increased pituitary adenoma incidence J:50053
\Col4a2em1(IMPC)Wtsi/\Col4a2em1(IMPC)Wtsi
(C57BL/6N-Col4a2em1(IMPC)Wtsi/WtsiOulu) 		increased trigeminal neuroma incidence J:239583
\Coro1ctm1c(KOMP)Wtsi/\Coro1ctm1c(KOMP)Wtsi
\Ptentm2Mak/\Ptentm2Mak
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(GFAP-cre/Esr1*,-lacZ)ASbk/0
(involves: 129P2/OlaHsd * C57BL/6N * FVB/NJ) 		increased glioblastoma incidence J:290447
\Csf2tm1Mlg/\Csf2tm1Mlg
\Ifngtm1Ts/\Ifngtm1Ts
\Il3tm1Glli/\Il3tm1Glli
(B6.129S-Csf2tm1Mlg Il3tm1Glli Ifngtm1TsIfngtm1Ts) 		increased pituitary adenoma incidence J:145518
\Ctnnb1tm1Mmt/\Ctnnb1+
\Pik3catm1Gilb/\Pik3ca+
\Trp53tm1Brn/\Trp53+
\Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA) 		increased medulloblastoma incidence J:186709
\Ctnnb1tm1Mmt/\Ctnnb1+
\Sox2tm1.1(cre/ERT2)Jpmb/\Sox2+
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6) 		increased pituitary gland tumor incidence J:201265
\Ctnnb1tm1Mmt/\Ctnnb1+
\Trp53tm1Brn/\Trp53+
\Tg(Fabp7-cre,-lacZ)3Gtm/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * CBA) 		increased medulloblastoma incidence J:186709
\Cul9tm1.2Yxi/\Cul9+
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased pituitary gland tumor incidence J:170976
\Cul9tm1.2Yxi/\Cul9tm1.2Yxi
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased pituitary gland tumor incidence J:170976
\Cxcr6tm1Lex/\Cxcr6+
(involves: 129S/SvEvBrd * C57BL/6J) 		increased medulloblastoma incidence J:120952
\Cxcr6tm1Lex/\Cxcr6tm1Lex
(involves: 129S/SvEvBrd * C57BL/6J) 		increased medulloblastoma incidence J:120952
\Dmtf1tm1Cjs/\Dmtf1+
\Krastm2Tyj/\Kras+
(involves: 129S2/SvPas * C57BL/6) 		increased neurofibroma incidence J:126002
\Drd2tm1Ebo/\Drd2tm1Ebo
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary adenoma incidence J:41857
\E2f1tm1Njd/\E2f1tm1Njd
\Rb1tm1Tyj/\Rb1+
(either: 129S2/SvPas or (involves: 129S2/SvPas * C57BL/6)) 		increased pituitary gland tumor incidence J:47108
\E2f4tm1Lees/\E2f4+
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary gland tumor incidence J:81082
\Ehbp1l1tm1a(EUCOMM)Wtsi/\Ehbp1l1tm1a(EUCOMM)Wtsi
(C57BL/6N-Ehbp1l1tm1a(EUCOMM)Wtsi/Wtsi) 		increased trigeminal neuroma incidence J:239583
\Foxo3tm1.1Rdp/\Foxo3+
\Foxo4tm1.1Rdp/\Foxo4tm1.1Rdp
(involves: 129S1/Sv * 129S6/SvEvTac * FVB/N) 		increased pituitary adenoma incidence J:118179
\Foxo3tm1.1Rdp/\Foxo3tm1.1Rdp
(involves: 129S6/SvEvTac * FVB/N) 		increased prolactinoma incidence J:118179
\Foxo3tm1.1Rdp/\Foxo3tm1.1Rdp
\Foxo4tm1.1Rdp/\Foxo4tm1.1Rdp
(involves: 129S1/Sv * 129S6/SvEvTac * FVB/N) 		increased pituitary adenoma incidence J:118179
\Gas2l2tm1a(KOMP)Wtsi/\Gas2l2tm1a(KOMP)Wtsi
(C57BL/6N-Gas2l2tm1a(KOMP)Wtsi/Wtsi) 		increased trigeminal neuroma incidence J:239583
\Gli1tm3(cre/ERT2)Alj/\Gli1+
\Gt(ROSA)26Sortm1(Smo/EYFP)Amc/\Gt(ROSA)26Sortm1(Smo/EYFP)Amc
(involves: 129S6/SvEvTac * 129X1/SvJ) 		increased medulloblastoma incidence J:139574
\Gpr37l1tm1.2Gtva/\Gpr37l1tm1.2Gtva
\Ptch1tm1Zim/\Ptch1+
(STOCK Gpr37l1tm1.2Gtva Ptch1tm1Zim/Cnrm) 		increased medulloblastoma incidence J:272049
\Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/\Gt(ROSA)26Sor+
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(Gfap-cre)2Brn/0
(either: (involves: 129 * 129P2/OlaHsd * FVB/N) or (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N)) 		increased pituitary gland tumor incidence J:187257
\Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/\Gt(ROSA)26Sor+
\Rb1tm2Brn/\Rb1tm2Brn
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(Gfap-cre)2Brn/0
(either: (involves: 129 * 129P2/OlaHsd * FVB/N) or (involves: 129 * 129P2/OlaHsd * C57BL/6 * FVB/N)) 		increased medulloblastoma incidence J:187257
increased pituitary gland tumor incidence J:187257
\Gt(ROSA)26Sortm1(CAG-Bmi1,-EGFP)Nki/\Gt(ROSA)26Sor+
\Tg(Gfap-cre)2Brn/0
(either: (involves: 129P2/OlaHsd * FVB/N) or (involves: 129P2/OlaHsd * C57BL/6 * FVB/N)) 		increased pituitary gland tumor incidence J:187257
\Gt(ROSA)26Sortm1(CAG-MYCN,-luc)Jhsc/\Gt(ROSA)26Sor+
\Tg(Dbh-icre)1Gsc/0
(involves: 129S6/SvEvTac * C57BL/6) 		increased neuroblastoma incidence J:222527
\Gt(ROSA)26Sortm1(RICTOR)Jger/\Gt(ROSA)26Sortm1(RICTOR)Jger
\Tg(GFAP-cre)25Mes/0
(involves: 129 * FVB/N) 		increased glioma incidence J:192206
increased oligodendroglioma incidence J:192206
\Gt(ROSA)26Sortm1(RICTOR)Jger/\Gt(ROSA)26Sortm1(RICTOR)Jger
\Tg(GFAP-cre)25Mes/0
\Tg(GFAP-EGFR*,-lacZ)#Agu/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased astrocytoma incidence J:192206
increased glioma incidence J:192206
increased oligodendroglioma incidence J:192206
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\Hprt1tm1(sb-Onco-Array)Peli/Y
(involves: 129S7/SvEvBrd) 		increased medulloblastoma incidence J:166283
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\Hprt1tm1(sb-Onco-Array)Peli/\Hprt1+
(involves: 129S7/SvEvBrd) 		increased medulloblastoma incidence J:166283
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6057Njen/0
(involves: C3H * C57BL/6) 		increased medulloblastoma incidence J:102234
\Gt(ROSA)26Sortm1(sb11)Njen/\Gt(ROSA)26Sor+
\TgTn(sb-T2/Onc2)6070Njen/0
(involves: C3H * C57BL/6) 		increased medulloblastoma incidence J:102234
\Gt(ROSA)26Sortm1(Smo/EYFP)Amc/?
\Tg(CAG-cre/Esr1*)5Amc/?
(involves: 129X1/SvJ * C57BL/6 * CBA) 		increased medulloblastoma incidence J:114992
\Gt(ROSA)26Sortm1(Smo/EYFP)Amc/\Gt(ROSA)26Sor+
\Hk2tm1.1Uku/\Hk2+
\Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N) 		increased medulloblastoma incidence J:210113
\Gt(ROSA)26Sortm1(Smo/EYFP)Amc/\Gt(ROSA)26Sor+
\Hk2tm1.1Uku/\Hk2tm1.1Uku
\Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6 * FVB/N) 		increased medulloblastoma incidence J:210113
\Gt(ROSA)26Sortm1(Smo/EYFP)Amc/\Gt(ROSA)26Sortm1(Smo/EYFP)Amc
\Olig2tm2(TVA,cre)Rth/\Olig2+
(involves: 129 * 129X1/SvJ) 		increased medulloblastoma incidence J:139574
\Gt(ROSA)26Sortm1(Smo/EYFP)Amc/\Gt(ROSA)26Sortm1(Smo/EYFP)Amc
\Tg(Atoh1-cre/Esr1*)14Fsh/0
(involves: 129X1/SvJ * FVB/N) 		increased medulloblastoma incidence J:139574
\Gt(ROSA)26Sortm1(Smo/EYFP)Amc/\Gt(ROSA)26Sortm1(Smo/EYFP)Amc
\Tg(GFAP-cre)25Mes/0
(involves: 129X1/SvJ * FVB/N) 		increased medulloblastoma incidence J:139574
\Gt(ROSA)26Sortm1(Smo/EYFP)Amc/\Gt(ROSA)26Sortm1(Smo/EYFP)Amc
\Tlx3tm1(cre)Qima/\Tlx3+
(involves: 129X1/SvJ) 		increased medulloblastoma incidence J:139574
\Gt(ROSA)26Sortm1(Smo/EYFP)Amc/\Gt(ROSA)26Sortm2(EGFP/cre)Alj
\Pgbd5tm1.1Aken/\Pgbd5tm1.1Aken
(involves: 129 * C57BL/6J * C57BL/6NTac * SW) 		increased medulloblastoma incidence J:346387
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sortm1Sor
\Ptentm1Mro/\Ptentm1Mro
\Rb1tm2Brn/\Rb1tm2Brn
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129 * 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased nervous system tumor incidence J:204385
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sortm1Sor
\Ptentm1Mro/\Ptentm1Mro
\Slc1a3tm1(cre/ERT2)Mgoe/\Slc1a3+
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S2/SvPas * 129S4/SvJaeSor) 		increased astrocytoma incidence J:229481
increased glioma incidence J:229481
increased oligodendroglioma incidence J:229481
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sortm1Sor
\Ptentm1Mro/\Ptentm1Mro
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB) 		increased astrocytoma incidence J:204385
increased glioma incidence J:204385
increased oligodendroglioma incidence J:204385
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sortm1Sor
\Ptentm1Mro/\Ptentm1Mro
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S4/SvJaeSor) 		increased astrocytoma incidence J:229481
increased glioma incidence J:229481
increased oligodendroglioma incidence J:229481
\Gt(ROSA)26Sortm1Sor/\Gt(ROSA)26Sortm1Sor
\Rb1tm2Brn/\Rb1tm2Brn
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129 * 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6 * FVB/N) 		increased nervous system tumor incidence J:204385
\Gt(ROSA)26Sortm2(CAG-Lin28b,-luc)Jhsc/\Gt(ROSA)26Sor+
\Tg(Dbh-icre)1Gsc/0
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6) 		increased neuroblastoma incidence J:241988
\Gt(ROSA)26Sortm2(myc*T58A)Rcse/\Gt(ROSA)26Sortm2(myc*T58A)Rcse
\Tg(Wap-cre)11738Mam/0
(involves: 129 * C57BL/6 * SJL) 		increased brain tumor incidence J:169403
increased pituitary gland tumor incidence J:169403
\Gt(ROSA)26Sortm2Thl/\Gt(ROSA)26Sor+
\Ptentm1Hwu/\Ptentm1Hwu
\Trp53tm1Thl/\Trp53tm1Thl
\Tyrc-Brd/\Tyrc-Brd
(involves: 129/Sv * 129S4/SvJae * C57BL/6) 		increased glioblastoma incidence J:172585
\Gt(ROSA)26Sortm2Thl/\Gt(ROSA)26Sor+
\Ptentm1Hwu/\Ptentm1Hwu
\Tyrc-Brd/\Tyrc-Brd
(involves: 129/Sv * 129S4/SvJae * C57BL/6) 		increased glioblastoma incidence J:172585
\Gt(ROSA)26Sortm3(myc*S62A)Rcse/\Gt(ROSA)26Sortm3(myc*S62A)Rcse
\Tg(Wap-cre)11738Mam/0
(involves: 129 * C57BL/6 * SJL) 		increased brain tumor incidence J:169403
\HelqGt(RRF112)Byg/\Helq+
(involves: 129P2/OlaHsd * C57BL/6) 		increased pituitary adenoma incidence J:206104
\HelqGt(RRF112)Byg/\HelqGt(RRF112)Byg
(involves: 129P2/OlaHsd * C57BL/6) 		increased pituitary adenoma incidence J:206104
\Htatip2tm1Hx/\Htatip2+
(involves: 129P2/OlaHsd * C57BL/6J) 		increased neuroblastoma incidence J:87066
\Kdm5atm1.1Kael/\Kdm5a+
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N) 		increased pituitary gland tumor incidence J:175625
\Kdm5atm1.1Kael/\Kdm5atm1.1Kael
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N) 		increased pituitary gland tumor incidence J:175625
\Kifbptm1a(KOMP)Wtsi/\Kifbptm1a(KOMP)Wtsi
(C57BL/6N-Kifbptm1a(KOMP)Wtsi/Wtsi) 		increased trigeminal neuroma incidence J:239583
\Krastm4Tyj/\Kras+
\Ptentm1Hwu/\Pten+
\Tg(Gfap-cre)77.6Mvs/0
(involves: 129S4/SvJae * BALB/c * C57BL/6NHsd) 		increased neurofibroma incidence J:154673
increased neurofibrosarcoma incidence J:154673
\Lig4tm1Icrf/\Lig4tm1Icrf
\Trp53tm1Tyj/\Trp53tm1Tyj
(either: (involves: 129P2/OlaHsd * 129S2/SvPas) or (involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ)) 		increased medulloblastoma incidence J:111068
\Lig4tm1Pmc/\Lig4tm1Pmc
\Trp53tm1Tyj/\Trp53+
\Xrcc2tm2Pmc/\Xrcc2tm2Pmc
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
\Lig4tm1Pmc/\Lig4tm1Pmc
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
\Lig4tm1Pmc/\Lig4tm1Pmc
\Trp53tm1Tyj/\Trp53tm1Tyj
\Xrcc2tm2Pmc/\Xrcc2tm2Pmc
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
\Lig4tm2.1Fwa/\Lig4tm2.1Fwa
(involves: 129S6/SvEvTac) 		increased medulloblastoma incidence J:157574
\Men1tm1.1Ctre/\Men1+
(involves: 129S6/SvEvTac * FVB/N) 		increased pituitary adenohypophysis tumor incidence J:133299
\Men1tm1.1Ctre/\Men1+
(involves: 129S6/SvEvTac * C57BL/6) 		increased pituitary gland tumor incidence J:120835
\Men1tm1.1Ctre/\Men1+
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J * FVB/N) 		increased pituitary adenohypophysis tumor incidence J:133299
increased pituitary melanotroph tumor incidence J:133299
\Men1tm1.1Gfk/\Men1+
(involves: 129T2/SvEms * C57BL/6) 		increased pituitary adenoma incidence J:116086
increased prolactinoma incidence J:116086
\Men1tm1Ctre/\Men1+
(either: (involves: 129S6/SvEvTac * FVB/N) or (involves: 129S6/SvEvTac * Black Swiss * FVB/N)) 		increased pituitary adenoma incidence J:67128
increased prolactinoma incidence J:67128
\Men1tm1Gfk/\Men1tm1Gfk
\Tg(Ins2-cre)25Mgn/0
(involves: 129T2/SvEms * C57BL/6 * C57BL/6J * DBA) 		increased prolactinoma incidence J:89898
\Men1tm1Rvt/\Men1+
(involves: 129 * C57BL/6) 		increased pituitary adenohypophysis tumor incidence J:191261
increased pituitary gland tumor incidence J:191261
\Men1tm1Zqw/\Men1+
(involves: 129/Sv * 129P2/OlaHsd) 		increased pituitary adenohypophysis tumor incidence J:85302
increased prolactinoma incidence J:85302
\Men1tm2.1Gfk/\Men1+
(involves: 129T2/SvEms * C57BL/6) 		increased pituitary adenoma incidence J:116086
\Mir34atm1.2Arte/\Mir34a+
\Tg(Neurod2-Smo*A1)199Jols/0
(involves: C57BL/6 * C57BL/6N) 		increased medulloblastoma incidence J:221990
\Mir34atm1.2Arte/\Mir34atm1.2Arte
\Tg(Neurod2-Smo*A1)199Jols/0
(involves: C57BL/6 * C57BL/6N) 		increased medulloblastoma incidence J:221990
\Mldhrtm1Zhgn/\Mldhrtm1Zhgn
\Tg(GFAP-cre)25Mes/0
(involves: FVB/N) 		increased glioblastoma incidence J:303725
\Morc2aem1(IMPC)Wtsi/\Morc2aem1(IMPC)Wtsi
(C57BL/6N-Morc2aem1(IMPC)Wtsi/WtsiOulu) 		increased trigeminal neuroma incidence J:239583
\Msh2tm1Htr/\Msh2tm1Htr
(involves: 129P2/OlaHsd) 		increased brain tumor incidence J:45433
\Msh2tm1Whl/\Msh2tm1Whl
\Rb1tm1Brd/\Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased pituitary adenohypophysis tumor incidence J:79016
increased pituitary melanotroph tumor incidence J:79016
\Ndrg2tm1Kmori/\Ndrg2+
(involves: C57BL/6 * C57BL/6NCrlj * CBA/JNCrlj) 		increased brain tumor incidence J:210264
\Nf1tm1.1Kest/\Nf1tm1c(KOMP)Wtsi
\Tg(Dhh-cre)1Mejr/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * C57BL/6NTac * FVB/N) 		increased neurofibroma incidence J:234172
\Nf1tm1c(KOMP)Wtsi/\Nf1tm1c(KOMP)Wtsi
\Tg(Dhh-cre)1Mejr/0
(involves: 129S4/SvJaeSor * C57BL/6 * C57BL/6N * FVB/N) 		increased neurofibroma incidence J:234172
\Nf1tm1Fcr/\Nf1+
\Tg(GFAP-cre)#Gtm/0
(involves: 129S/SvEv * 129S4/SvJae * C57BL/6 * CBA) 		increased glioma incidence J:176586
\Nf1tm1Fcr/\Nf1+
\Trp53tm1Brd/\Trp53+
(B6.129-Trp53tm1Brd Nf1tm1Fcr) 		increased brain tumor incidence J:95933
\Nf1tm1Fcr/\Nf1+
\Trp53tm1Tyj/\Trp53+
(involves: 129S/SvEv * 129S2/SvPas * C57BL/6) 		increased neuroblastoma incidence J:58877
increased neurofibrosarcoma incidence J:58877
\Nf1tm1Fcr/\Nf1tm1Fcr
\Trp53tm1Elee/\Trp53tm1Elee
\Tg(GFAP-cre)25Mes/0
(involves: 129S/SvEv * 129S4/SvJae * FVB/N) 		increased glioma incidence J:149662
\Nf1tm1Par/\Nf1+
\Ptentm1Hwu/\Pten+
\Trp53tm1Elee/\Trp53+
\Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N) 		increased astrocytoma incidence J:134611
increased brain tumor incidence J:134611
\Nf1tm1Par/\Nf1+
\Ptentm1Hwu/\Pten+
\Trp53tm1Tyj/\Trp53+
\Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S2/SvPas * 129S4/SvJae * 129X1/SvJ * FVB/N) 		increased astrocytoma incidence J:134611
increased brain tumor incidence J:134611
\Nf1tm1Par/\Nf1+
\Trp53tm1Elee/\Trp53+
\Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S4/SvJae * 129X1/SvJ * FVB/N) 		increased astrocytoma incidence J:134611
increased brain tumor incidence J:134611
\Nf1tm1Par/\Nf1+
\Trp53tm1Tyj/\Trp53+
\Tg(GFAP-cre)25Mes/0
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * FVB/N) 		increased astrocytoma incidence J:134611
increased brain tumor incidence J:134611
\Nf1tm1Par/\Nf1tm1Fcr
\Tg(GFAP-cre)#Gtm/0
(involves: 129S/SvEv * 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased glioma incidence J:165209
\Nf1tm1Par/\Nf1tm1Par
\H2az2Tg(Wnt1-cre)11Rth/\H2az2+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) 		increased ganglioneuroma incidence J:80323
increased gangliosarcoma incidence J:80323
\Nf1tm1Par/\Nf1tm1Par
\Tg(Mpz-cre)94Imeg/0
(involves: 129S1/Sv * 129X1/SvJ) 		increased ganglioneuroma incidence J:80323
increased gangliosarcoma incidence J:80323
\Nf1tm1Par/\Nf1tm1Par
\Tg(Pax3-cre)1Joe/0
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased ganglioneuroma incidence J:80323
increased gangliosarcoma incidence J:80323
\Nf1tm1Par/\Nf1tm1Tyj
\Tg(Mpz-cre)1Brn/0
(involves: 129/Sv * FVB/N) 		increased neurofibroma incidence J:131914
\Nf1tm1Tyj/?
\Nstr1C57BL/6J/\Nstr1C57BL/6J
\Trp53tm1Tyj/?
(involves: 129S2/SvPas * A/J * C57BL/6J) 		increased neurofibrosarcoma incidence J:105038
\Nf1tm1Tyj/?
\Trp53tm1Tyj/?
\MastrC57BL/6J/?
(involves: 129S2/SvPas * 129S4/SvJae * C57BL/6J) 		increased astrocytoma incidence J:92444
\Nf1tm1Tyj/\Nf1+
(involves: 129S2/SvPas * C57BL/6) 		increased neurofibrosarcoma incidence J:18542
\Nf1tm1Tyj/\Nf1+
\Suz12Gt(Betageo)1Khe/\Suz12+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased neurofibroma incidence J:217077
increased neurofibrosarcoma incidence J:217077
increased Schwannoma incidence J:217077
\Nf1tm1Tyj/\Nf1+
\Suz12Gt(Betageo)1Khe/\Suz12+
\Trp53tm1Tyj/\Trp53+
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased glioma incidence J:217077
increased neurofibrosarcoma incidence J:217077
\Nf1tm1Tyj/\Nf1+
\Tg(Th-MYCN)41Waw/0
(involves: 129S2/SvPas * BALB/c * C57BL/6J) 		increased neuroblastoma incidence J:41126
\Nf1tm1Tyj/\Nf1+
\Trp53tm1Tyj/\Trp53+
(involves: 129/Sv * C57BL/6) 		increased neurofibrosarcoma incidence J:58876
\Nf1tm1Tyj/\Nf1+
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas) 		increased neurofibrosarcoma incidence J:131914
\Nf1tm1Tyj/\Nf1+
\Trp53tm1Tyj/\Trp53+
(B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +) 		increased astrocytoma incidence J:64364
increased brain tumor incidence J:64364
increased glioblastoma incidence J:64364
\Nf1tm1Tyj/\Nf1+
\Trp53tm1Tyj/\Trp53+
((C3H/HeJ x B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +)F1) 		increased astrocytoma incidence J:64364
increased brain tumor incidence J:64364
increased glioblastoma incidence J:64364
\Nf1tm1Tyj/\Nf1+
\Trp53tm1Tyj/\Trp53+
((CAST/EiJ x B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +)F1) 		increased astrocytoma incidence J:64364
increased brain tumor incidence J:64364
increased glioblastoma incidence J:64364
\Nf1tm1Tyj/\Nf1+
\Trp53tm1Tyj/\Trp53+
((CBA/J x B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +)F1) 		increased brain tumor incidence J:64364
\Nf1tm1Tyj/\Nf1+
\Trp53tm1Tyj/\Trp53+
((SJL/J x B6.129S2-Trp53tm1Tyj Nf1tm1Tyj/+ +)F1) 		increased astrocytoma incidence J:64364
increased brain tumor incidence J:64364
increased glioblastoma incidence J:64364
\Nf1tm1Tyj/\Nf1+
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased glioma incidence J:217077
increased neuroblastoma incidence J:217077
increased neurofibrosarcoma incidence J:217077
\Nf1tm1Tyj/\Nf1tm2Tyj
(chimera involves: 129S2/SvPas) 		increased neurofibroma incidence J:58876
\Nf2tm1Gth/\Nf2+
(involves: 129P2/OlaHsd * FVB/N) 		increased neurofibroma incidence J:63264
increased neurofibrosarcoma incidence J:63264
\Nf2tm1Gth/\Nf2tm2Gth
\Tg(Mpz-cre)#Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased neurofibrosarcoma incidence J:63264
increased Schwannoma incidence J:63264
\Nf2tm2Gth/\Nf2+
\Trp53tm1Brd/\Trp53+
\Tg(Mpz-cre)3Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N) 		increased neurofibrosarcoma incidence J:92413
\Nf2tm2Gth/\Nf2+
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased Schwannoma incidence J:132943
\Nf2tm2Gth/\Nf2tm2Gth
(involves: 129P2/OlaHsd * FVB/N) 		increased meningioma incidence J:173718
\Nf2tm2Gth/\Nf2tm2Gth
\Ptgdstm1.1(cre)Gvn/\Ptgds+
(involves: 129P2/OlaHsd * FVB/N) 		increased meningioma incidence J:173718
increased pituitary adenoma incidence J:173718
\Nf2tm2Gth/\Nf2tm2Gth
\Ptgdstm1.1(cre)Gvn/\Ptgds+
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * FVB/N) 		increased nervous system tumor incidence J:173718
\Nf2tm2Gth/\Nf2tm2Gth
\Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased neurofibrosarcoma incidence J:92413
increased Schwannoma incidence J:63264, J:92413
\Nf2tm2Gth/\Nf2tm2Gth
\Tg(Mpz-cre)3Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased neurofibrosarcoma incidence J:63264
increased Schwannoma incidence J:63264, J:92413
\Nf2tm2Gth/\Nf2tm2Gth
\Tg(Mpz-cre)4Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased Schwannoma incidence J:63264
\Nf2tm2Gth/\Nf2tm2Gth
\Tg(Mpz-cre)#Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased neurofibrosarcoma incidence J:63264
\Nf2tm2Gth/\Nf2tm2Gth
\Tg(Postn-cre)1Sjc/0
(involves: 129P2/OlaHsd * FVB/NTac) 		increased neurofibrosarcoma incidence J:216420
increased Schwannoma incidence J:216420
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brd/\Trp53+
\Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N) 		increased nervous system tumor incidence J:92413
increased neurofibroma incidence J:92413
increased neurofibrosarcoma incidence J:92413
increased Schwannoma incidence J:92413
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brd/\Trp53+
\Tg(Mpz-cre)3Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N) 		increased neurofibrosarcoma incidence J:92413
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brd/\Trp53tm1Brd
\Tg(Mpz-cre)2Brn/0
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N) 		increased neurofibrosarcoma incidence J:92413
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brn/\Trp53+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased Schwannoma incidence J:132943
\Nf2tm2Gth/\Nf2tm2Gth
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * 129S7/SvEvBrd) 		increased Schwannoma incidence J:132943
\Nhej1tm1Fwa/\Nhej1tm1Fwa
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129) 		increased medulloblastoma incidence J:138774
\Nsun2tm1a(EUCOMM)Wtsi/\Nsun2tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Nsun2tm1a(EUCOMM)Wtsi/Wtsi) 		increased trigeminal neuroma incidence J:239583
\Pgbd5tm1.1Aken/\Pgbd5tm1.2Aken
\Ptch1tm1Bjw/\Ptch1tm1Bjw
\Ptf1atm1.1(cre)Cvw/\Ptf1a+
(involves: 129 * C57BL/6J * C57BL/6NTac * FVB/N * SW) 		increased medulloblastoma incidence J:346387
\Polbtm1a(KOMP)Wtsi/\Polbtm1a(KOMP)Wtsi
(C57BL/6N-Polbtm1a(KOMP)Wtsi/Wtsi) 		increased trigeminal neuroma incidence J:239583
\Pomctm1Low/\Pomc+
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2) 		increased pituitary adenoma incidence J:119240
\Pomctm1Low/\Pomc+
\Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster) 		increased pituitary adenoma incidence J:119240
\Pomctm1Low/\Pomctm1Low
(involves: 129S2/SvPas * 129X1/SvJ * C57BL/6 * DBA/2) 		increased pituitary adenoma incidence J:119240
\Pomctm1Low/\Pomctm1Low
\Tg(Pomc)#Low/0
(involves: 129 * C57BL/6 * CBA * DBA/2 * Swiss Webster) 		increased pituitary adenoma incidence J:119240
\Prdm2tm1Shg/\Prdm2+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary adenoma incidence J:71406
\Prdm2tm1Shg/\Prdm2tm1Shg
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary adenoma incidence J:71406
\Prkar1atm1.1Lsk/\Prkar1a+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased Schwannoma incidence J:160299
\Prkar1atm1.2Lsk/\Prkar1atm1.2Lsk
\Tg(Ghrhr-cre)3242Lsk/0
(involves: 129S1/Sv * 129X1/SvJ * FVB/N) 		increased pituitary gland tumor incidence J:130264
\Prkar1atm1.2Lsk/\Prkar1atm1.2Lsk
\Tg(Tyr-cre)3Gfk/0
(either: (involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA) or (involves: 129S1/Sv * 129X1/SvJ * C57BL/6)) 		increased Schwannoma incidence J:98799
\Prltm1Hmn/\Prltm1Hmn
(involves: 129S2/SvPas) 		increased pituitary adenoma incidence J:79661
\Prmt7tm1a(EUCOMM)Wtsi/\Prmt7tm1a(EUCOMM)Wtsi
(B6JTyr;B6N-Prmt7tm1a(EUCOMM)Wtsi/Wtsi) 		increased trigeminal neuroma incidence J:239583
\Psphtm1a(EUCOMM)Hmgu/\Psphtm1a(EUCOMM)Hmgu
(C57BL/6N-Psphtm1a(EUCOMM)Hmgu/Wtsi) 		increased trigeminal neuroma incidence J:239583
\Ptch1tm1.1Hahn/\Ptch1+
(involves: 129 * BALB/c * C57BL/6 * FVB/N) 		increased medulloblastoma incidence J:149148
\Ptch1tm1Bjw/\Ptch1tm1Bjw
\Tg(Atoh1-cre)1Bfri/0
(involves: 129T2/SvEms * C57BL/6 * CBA) 		increased medulloblastoma incidence J:139573
\Ptch1tm1Bjw/\Ptch1tm1Bjw
\Tg(Atoh1-cre/Esr1*)14Fsh/0
(involves: 129T2/SvEms * FVB/N) 		increased medulloblastoma incidence J:139573
\Ptch1tm1Bjw/\Ptch1tm1Bjw
\Tg(GFAP-cre)25Mes/0
(involves: 129T2/SvEms * FVB/N) 		increased medulloblastoma incidence J:139573
\Ptch1tm1Cklr/\Ptch1+
\Pax7tm1(cre)Mrc/\Pax7+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased medulloblastoma incidence J:159972
\Ptch1tm1Cklr/\Ptch1+
\Trp53tm1Brn/?
\Pax7tm1(cre)Mrc/\Pax7+
(involves: 129P2/OlaHsd * 129S1/Sv * 129X1/SvJ * C57BL/6 * SJL) 		increased medulloblastoma incidence J:159972
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased medulloblastoma incidence J:205254
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased medulloblastoma incidence J:42441
\Ptch1tm1Mps/\Ptch1+
(involves: 129S1/Sv * 129X1/SvJ) 		increased medulloblastoma incidence J:144811, J:114992, J:102702
\Ptch1tm1Mps/\Ptch1+
\Ptch2tm1Pmc/\Ptch2tm1Pmc
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6) 		increased medulloblastoma incidence J:112118
\Ptch1tm1Mps/\Ptch1+
\Tg(Atoh1-GFP)1Jejo/?
(involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * DBA/2) 		increased medulloblastoma incidence J:144811
\Ptch1tm1Mps/\Ptch1+
\Tg(Atoh1-sb11)1Mtay/0
\TgTn(sb-T2/Onc3)12740Njen/0
(involves: 129S1/Sv * 129X1/SvJ * C3H * C57BL/6J * ICR) 		increased medulloblastoma incidence J:181542
\Ptch1tm1Mps/\Ptch1+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129 * 129S2/SvPas * C57BL/6) 		increased medulloblastoma incidence J:125534
\Ptch1tm1Zim/\Ptch1+
(either: (involves: 129 * C57BL/6) or (involves: 129 * CD-1)) 		increased medulloblastoma incidence J:47421
\Ptch1tm1Zim/\Ptch1+
(involves: 129 * CD-1) 		increased medulloblastoma incidence J:79666, J:165388
\Ptentm1Rdp/\Pten+
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * 129S6/SvEvTac * C57BL/6 * FVB/N) 		increased astrocytoma incidence J:140704
increased glioblastoma incidence J:140704
increased glioma incidence J:140704
\Ptentm2.1Ppp/\Pten+
\Tg(Cnp-EGFR)10Nrat/0
\Tg(Dhh-cre)1Mejr/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL) 		increased neurofibrosarcoma incidence J:195067
\Ptentm2.1Ppp/\Ptentm2.1Ppp
\Tg(Cnp-EGFR)10Nrat/0
\Tg(Dhh-cre)1Mejr/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL) 		increased neurofibrosarcoma incidence J:195067
\Ptentm2.1Ppp/\Ptentm2.1Ppp
\Tg(Dhh-cre)1Mejr/0
(involves: 129S1/Sv * C57BL/6 * FVB/N * SJL) 		increased neurofibrosarcoma incidence J:195067
\Ptentm2.1Ppp/\Ptentm2.1Ppp
\Tg(GFAP-TAg121)1Tvd/0
(involves: 129S1/Sv * C57BL/6 * C57BL/6J * DBA/2 * FVB/N) 		increased astrocytoma incidence J:99385
\Ptentm2Mak/\Ptentm2Mak
\Tg(GFAP-cre/Esr1*,-lacZ)ASbk/0
\Trp53tm1Brn/\Trp53tm1Brn
(involves: 129P2/OlaHsd * FVB/NJ) 		increased glioblastoma incidence J:290447
\Ptentm2Mak/\Ptentm2Mak
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(Nes-cre/ERT2,-ALPP)1Sbk/0
(involves: 129P2/OlaHsd) 		increased glioma incidence J:237990
increased medulloblastoma incidence J:237990
\Rag1tm1Mom/\Rag1tm1Mom
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL) 		increased medulloblastoma incidence J:141515
increased pituitary adenoma incidence J:141515
\Rag1tm1Mom/\Rag1tm1Mom
\Trp53tm1Brd/\Trp53tm1Brd
\Xrcc5tm1Dbr/\Xrcc5tm1Dbr
(involves: 129S7/SvEvBrd * C57BL) 		increased medulloblastoma incidence J:141515
\Rb1tm1Brd/\Rb1+
(involves: 129S7/SvEvBrd * C57BL/6) 		increased brain tumor incidence J:2516
increased pituitary adenoma incidence J:17434
\Rb1tm1Brd/\Rb1+
(involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6J) 		increased pituitary adenohypophysis tumor incidence J:79016
increased pituitary melanotroph tumor incidence J:79016
\Rb1tm1Brn/\Rb1+
\Tg(Pomc-FLP)1aBrn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased pituitary adenoma incidence J:48860
\Rb1tm1Brn/\Rb1tm1Brn
\Tg(Pomc-FLP)1aBrn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased pituitary adenoma incidence J:48860
\Rb1tm1Brn/\Rb1tm1Brn
X/\Tg(Pomc-FLP)1bBrn
(involves: 129P2/OlaHsd * FVB/N) 		increased pituitary adenoma incidence J:48860
\Rb1tm1Mlh/\Rb1+
(either: 129P2/OlaHsd-Rb1tm1Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)) 		increased pituitary melanotroph tumor incidence J:20542
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary gland tumor incidence J:81082, J:2511
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * C57BL/6J) 		increased pituitary adenohypophysis tumor incidence J:133299
increased pituitary melanotroph tumor incidence J:133299
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas * 129S6/SvEvTac * FVB/N) 		increased pituitary gland tumor incidence J:175625
\Rb1tm1Tyj/\Rb1+
(involves: 129S2/SvPas) 		increased pituitary gland tumor incidence J:215358
\Rb1tm1Tyj/\Rb1+
\Rbl1tm1Tyj/\Rbl1+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary gland tumor incidence J:34058
\Rb1tm1Tyj/\Rb1+
\Rbl1tm1Tyj/\Rbl1tm1Tyj
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary gland tumor incidence J:34058
\Rb1tm1Tyj/\Rb1+
\Smarca4tm1Mag/\Smarca4+
(involves: 129S/Sv * 129S2/SvPas * C57BL/6J * CD-1) 		increased pituitary gland tumor incidence J:132091
\Rb1tm1Tyj/\Rb1+
\Tg(S100b-v-erbB)4496Waw/0
(involves: 129S2/SvPas * C57BL/6J * DBA/2J * FVB/N) 		increased glioma incidence J:82649
\Rb1tm1Tyj/\Rb1+
\Tg(Th-MYCN)41Waw/0
(involves: 129S2/SvPas * BALB/c * C57BL/6J) 		increased neuroblastoma incidence J:41126
\Rb1tm1Tyj/\Rb1+
\Trim27Gt(XP0484)Wtsi/\Trim27Gt(XP0484)Wtsi
(involves: 129P2/OlaHsd * C57BL/6) 		increased pituitary gland tumor incidence J:189317
\Rb1tm1Tyj/\Rb1+
\Trp53tm1Tyj/\Trp53+
(involves: 129S2/SvPas * C57BL/6) 		increased pituitary melanotroph tumor incidence J:19542
\Rb1tm1Tyj/\Rb1tm2Tyj
(chimera involves: 129S2/SvPas * C57BL/6) 		increased pituitary adenoma incidence J:59268
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(Gfap-cre)2Brn/0
(involves: 129 * FVB/N) 		increased pituitary gland tumor incidence J:187257
\Rb1tm2Brn/\Rb1tm2Brn
\Tg(Rbp3-cre)1Brn/0
(involves: 129 * FVB/N) 		increased pituitary adenohypophysis tumor incidence J:77982
increased pituitary melanotroph tumor incidence J:77982
\Rb1tm2Brn/\Rb1tm2Brn
\Trp53tm1Brd/\Trp53tm1Brd
\Tg(Gfap-cre)2Brn/0
(involves: 129 * 129S7/SvEvBrd * FVB/N) 		increased medulloblastoma incidence J:61961
\Rb1tm2Brn/\Rb1tm2Brn
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(Gfap-cre)2Brn/0
(involves: 129P2/OlaHsd * FVB/N) 		increased medulloblastoma incidence J:61961
\Rb1tm2Brn/\Rb1tm2Brn
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(Gfap-cre)2Brn/0
(involves: 129 * 129P2/OlaHsd * FVB/N) 		increased medulloblastoma incidence J:187257
increased pituitary gland tumor incidence J:187257
\Rb1tm2Mlh/\Rb1+
(either: 129P2/OlaHsd-Rb1tm2Mlh or (involves: 129P2/OlaHsd * BALB/c) or (involves: 129P2/OlaHsd * FVB/N)) 		increased pituitary melanotroph tumor incidence J:20542
\Rb1tm3Tyj/\Rb1tm3Tyj
\Tg(Nes-cre)1Atp/0
(involves: 129S4/SvJae * FVB/N) 		increased pituitary gland tumor incidence J:91406
\Rb1tm3Tyj/\Rb1tm3Tyj
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(Nes-cre)1Atp/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N) 		increased pituitary gland tumor incidence J:91406
\Rettm2.1Cos/?
\Tg(Th-MYCN)41Waw/0
(involves: 129S1/Sv * BALB/c * C57BL/6J) 		increased neuroblastoma incidence J:261033
\Rettm2.1Cos/\Rettm2.1Cos
(involves: 129S1/Sv * C57BL/6J * FVB/N) 		increased ganglioneuroma incidence J:60659
\Rgsc1033/\Rgsc1033+
(involves: C57BL/6JJcl * DBA/2JJcl) 		increased pituitary adenoma incidence J:133634
\Rint1tm1Whl/\Rint1+
(Not Specified) 		increased pituitary adenoma incidence J:122805
\Rtel1tm2.1Hdin/\Rtel1tm2.1Hdin
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6) 		increased medulloblastoma incidence J:202812
\Smarcb1tm1Gvk/\Smarcb1+
(involves: 129/Sv * C57BL/6J * SJL/J) 		increased brain tumor incidence J:101185
\Smarcb1tm2Sho/\Smarcb1tm2Sho
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(GFAP-cre)#Gtm/0
(involves: 129P2/OlaHsd * 129S1/Sv * C57BL/6 * CBA) 		increased brain tumor incidence J:226786
\Sptbn1tm1Mish/\Sptbn1+
(involves: 129S6/SvEvTac) 		increased glioma incidence J:166879
\Ssr2tm1b(EUCOMM)Wtsi/\Ssr2tm1b(EUCOMM)Wtsi
(C57BL/6N-Ssr2tm1b(EUCOMM)Wtsi/Wtsi) 		increased trigeminal neuroma incidence J:239583
\SufuGt(XB699)Byg/\Sufu+
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6) 		increased medulloblastoma incidence J:125534
\Tg(AMH-Fshr*D580H)#Hht/0
(involves: FVB/N) 		increased prolactinoma incidence J:160015
\Tg(Atoh1-sb11)1Mtay/0
\TgTn(sb-T2/Onc3)12740Njen/0
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas * C3H * C57BL/6J * ICR) 		increased medulloblastoma incidence J:181542
\Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
\Tg(Dbh-icre)1Gsc/0
(involves: C57BL/6 * FVB/N) 		increased neuroblastoma incidence J:186696
\Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
\Tg(Dbh-icre)1Gsc/0
\Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6 * C57BL/6J * FVB/N) 		increased neuroblastoma incidence J:186696
\Tg(CAG-Alk*F1174L,-luc)60Jhsc/0
\Thtm1(cre)Te/\Th+
(involves: 129X1/SvJ * C57BL/6 * FVB/N) 		increased neuroblastoma incidence J:186696
\Tg(CMV-tTA)3Bjd/0
\Tg(tetO-Prkar1a*x2as)1Stra/0
(involves: C57BL/6 * NMRI * SJL) 		increased Schwannoma incidence J:95465
\Tg(Cnp-EGFR)10Nrat/0
(involves: C57BL/6 * SJL) 		increased neurofibroma incidence J:95933
\Tg(GFAP-Hras1)2Agu/0
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		increased astrocytoma incidence J:69129
\Tg(GFAP-Hras1)2Agu/\Tg(GFAP-Hras1)2Agu
(involves: 129S1/Sv * 129X1/SvJ * ICR) 		increased astrocytoma incidence J:69129
\Tg(GFAP-SRC)1Aag/0
(involves: C3H * C57BL/6) 		increased astrocytoma incidence J:40335
\Tg(GFAP-SRC)2Aag/0
(involves: C3H * C57BL/6) 		increased astrocytoma incidence J:40335
increased Schwannoma incidence J:40335
\Tg(GFAP-TAg121)1Tvd/0
(involves: C57BL/6 * DBA/2 * FVB/N) 		increased astrocytoma incidence J:77132
\Tg(GFAP-tTA)67Pop/0
\Tg(tetO-Ifng)184Pop/0
(B6.Cg-Tg(GFAP-tTA)67Pop Tg(tetO-Ifng)184Pop) 		increased medulloblastoma incidence J:94092
\Tg(GFAP-tTA)67Pop/0
\Tg(tetO-Ifng)184Pop/0
(involves: 129S/SvEv * C57BL/6 * DBA/2) 		increased medulloblastoma incidence J:94092
\Tg(GFAP-TVA)5Hev/0
(involves: BALB/c * C57BL/6 * FVB/N) 		increased glioma incidence J:125535
increased oligodendroglioma incidence J:125535
\Tg(Gh-Gal)4599Vron/?
(involves: C57BL/6 * CD-1 * SJL) 		increased pituitary adenoma incidence J:86486
\Tg(Mdm2)1Snj/0
(involves: 129S7/SvEvBrd * C57BL/6) 		increased pituitary adenoma incidence J:51661
\Tg(Mdm2)1Snj/0
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6) 		increased medulloblastoma incidence J:51661
\Tg(MMTV-NCOA3)#Mybr/0
(FVB/N-Tg(MMTV-NCOA3)#Mybr) 		increased pituitary adenoma incidence J:93548
\Tg(NES-TVA)J12Ech/0
(involves: FVB/N) 		increased glioma incidence J:125535
increased oligodendroglioma incidence J:125535
\Tg(NES-TVA)J12Ech/0
\Trp53tm1Brd/\Trp53+
(involves: 129 * C57BL/6 * FVB/N) 		increased glioma incidence J:52161
\Tg(Neurod2-Smo*A1)199Jols/0
(C57BL/6-Tg(Neurod2-Smo*A1)199Jols) 		increased medulloblastoma incidence J:93861
\Tg(Neurod2-Smo*A1)199Jols/0
(involves: C57BL/6) 		increased medulloblastoma incidence J:221990
\Tg(Neurod2-Smo*A1)199Jols/\Tg(Neurod2-Smo*A1)199Jols
(C57BL/6-Tg(Neurod2-Smo*A1)199Jols) 		increased medulloblastoma incidence J:133312, J:189258
\Tg(Neurod2-Smo*A2)#Jols/0
(C57BL/6-Tg(Neurod2-Smo*A2)#Jols) 		increased medulloblastoma incidence J:189258
\Tg(OMP-SV40T)13Bse/0
(involves: C57BL/6 * SJL) 		increased neuroblastoma incidence J:54269
\Tg(Prl-EGFR)#Sme/0
(Not Specified) 		increased prolactinoma incidence J:219654
\Tg(PyLT)1Vb/0
(Not Specified) 		increased pituitary adenoma incidence J:55528
increased pituitary gland tumor incidence J:55528
\Tg(Rbp3-SV40)IT-2Jjw/?
(involves: BALB/c * C57BL/6) 		increased pineal gland tumor incidence J:60231
\Tg(RBP3-TAg)#Ove/0
(involves: C57BL/6 * FVB/N) 		increased brain tumor incidence J:59267
\Tg(rTH-Tag)20Dmc/0
(involves: C57BL/6NTac * DBA/2NTac) 		increased brain tumor incidence J:90323
increased neuroblastoma incidence J:90323
\Tg(S100b-v-erbB)4496Waw/0
(involves: C57BL/6J * DBA/2J * FVB/N) 		increased oligodendroglioma incidence J:82649
\Tg(S100b-v-erbB)4496Waw/0
\Trp53tm1Brd/\Trp53+
(involves: 129S7/SvEvBrd * C57BL/6J * DBA/2J * FVB/N) 		increased glioma incidence J:82649
increased oligodendroglioma incidence J:82649
\Tg(S100b-v-erbB)4496Waw/0
\Trp53tm1Brd/\Trp53tm1Brd
(involves: 129S7/SvEvBrd * C57BL/6J * DBA/2J) 		increased glioma incidence J:225862
increased oligodendroglioma incidence J:225862
\Tg(Slc1a2-tTA)#Waw/0
\Tg(tetO-MYCN,-luc)#Waw/0
(involves: FVB/NJ) 		increased medulloblastoma incidence J:160518
\Tg(Slc1a2-tTA)#Waw/0
\Tg(tetO-MYCN,-luc)#Waw/\Tg(tetO-MYCN,-luc)#Waw
(involves: FVB/NJ) 		increased medulloblastoma incidence J:160518
\Tg(SV)7Bri/0
(C57BL/6J-Tg(SV)7Bri/J) 		increased brain tumor incidence J:94307
\Tg(SV)419Bri/\Tg(SV)419Bri
(C57BL/6J-Tg(SV)419Bri) 		increased brain tumor incidence J:147031
\Tg(SV)427Bri/0
(C57BL/6J-Tg(SV)427Bri) 		increased brain tumor incidence J:79096, J:147031
\Tg(tetO-TAg)2-5Hiwa/0
(involves: C57BL/6) 		increased neuroblastoma incidence J:156984, J:175962
\Tg(tetO-TAg,CMV-rtTA)123Yihu/0
(involves: FVB/N) 		increased medulloblastoma incidence J:141623
\Tg(Th-ALK*F1174L)2Loch/0
\Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6J * CBA) 		increased neuroblastoma incidence J:191012
\Tg(Th-MYCN)41Waw/0
(involves: BALB/c * C57BL/6J) 		increased neuroblastoma incidence J:41126
\Tg(Th-MYCN)41Waw/0
(involves: BALB/c * C57BL/6J * FVB/N) 		increased neuroblastoma incidence J:41126
\Tg(Th-MYCN)41Waw/0
(involves: 129X1/SvJ * BALB/c * C57BL/6J) 		increased neuroblastoma incidence J:172448
\Tg(Th-MYCN)41Waw/0
\Trp53tm1Brd/\Trp53+
(involves: 129S7/SvEvBrd * BALB/c * C57BL/6J * FVB/N) 		increased neuroblastoma incidence J:41126
\Tg(Th-MYCN)41Waw/\Tg(Th-MYCN)41Waw
(involves: BALB/c * C57BL/6J) 		increased neuroblastoma incidence J:41126
\Thrbtm1.1Syc/\Thrbtm1.1Syc
(involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6) 		increased pituitary adenoma incidence J:95391
\Trim37Gt(RRO307)Byg/\Trim37Gt(RRO307)Byg
(B6J.129P2-Trim37Gt(RRO307)Byg) 		increased medulloblastoma incidence J:232482
\Trp53Bbl/\Trp53+
(C57BL/6JSfdAnu-Trp53Bbl/Anu) 		increased brain tumor incidence J:104190
\Trp53bhy/\Trp53+
(C57BL/6JSfdAnu-Trp53bhy/Anu) 		increased brain tumor incidence J:104190
\Trp53tm1Brd/\Trp53tm1Brd
\Xrcc4tm2.1Fwa/\Xrcc4tm2Fwa
\Tg(Nes-cre)1Kln/0
(involves: 129S6/SvEvTac * 129S7/SvEvBrd * C57BL/6 * SJL) 		increased medulloblastoma incidence J:109585
\Trp53tm1Brd/\Trp53tm1Brd
\Xrcc5tm1Dbr/\Xrcc5tm1Dbr
(involves: 129S7/SvEvBrd * C57BL) 		increased medulloblastoma incidence J:141515
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(GFAP-cre)25Mes/0
(involves: 129P2/OlaHsd * C57BL/6 * FVB/N) 		increased astrocytoma incidence J:140704
\Trp53tm1Brn/\Trp53tm1Brn
\Tg(Nes-cre/ERT2,-ALPP)1Sbk/0
(involves: 129P2/OlaHsd) 		increased brain tumor incidence J:237990
increased medulloblastoma incidence J:237990
\Trp53tm1Brn/\Trp53tm1Tyj
\Tg(Nes-cre)1Kln/0
(involves: 129P2/OlaHsd * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:102702
\Trp53tm1Elee/\Trp53tm1Elee
\Tg(GFAP-cre)25Mes/0
(involves: 129S4/SvJae * FVB/N) 		increased glioma incidence J:149662
increased medulloblastoma incidence J:149662
\Trp53tm1Elee/\Trp53tm1Tyj
\Tg(GFAP-cre)25Mes/0
(involves: 129S2/SvPas * 129S4/SvJae * FVB/N) 		increased glioma incidence J:149662
increased medulloblastoma incidence J:149662
\Trp53tm1Tyj/\Trp53tm1Tyj
(involves: 129S2/SvPas) 		increased medulloblastoma incidence J:102702
\Trp53tm1Tyj/\Trp53tm1Tyj
\Xrcc2tm1Pmc/\Xrcc2tm1Pmc
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6) 		increased medulloblastoma incidence J:111068
\Trp53tm1Tyj/\Trp53tm1Tyj
\Xrcc2tm2Pmc/\Xrcc2tm2Pmc
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:144617
\Xpnpep1tm1a(KOMP)Wtsi/\Xpnpep1tm1a(KOMP)Wtsi
(C57BL/6N-Xpnpep1tm1a(KOMP)Wtsi/Wtsi) 		increased trigeminal neuroma incidence J:239583
\Xrcc1tm1Pmc/\Xrcc1tm1Pmc
\Trp53tm1Tyj/\Trp53+
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:152528
\Xrcc1tm1Pmc/\Xrcc1tm1Pmc
\Trp53tm1Tyj/\Trp53tm1Tyj
\Tg(Nes-cre)1Kln/0
(involves: 129S1/Sv * 129S2/SvPas * C57BL/6 * SJL) 		increased medulloblastoma incidence J:152528
Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support. 		last database update
03/25/2025
MGI 6.24 		The Jackson Laboratory